v3.23.2
Schedule of Anti-dilutive Excluded from Calculation of Diluted Net Loss Per Share (Details) (Parenthetical) - $ / shares
1 Months Ended 3 Months Ended 11 Months Ended 12 Months Ended
Dec. 31, 2022
Dec. 31, 2022
Mar. 31, 2023
Mar. 31, 2022
Dec. 12, 2022
Dec. 31, 2022
Dec. 31, 2021
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]              
Financial Designation, Predecessor and Successor [Fixed List] Successor Successor Successor Predecessor Predecessor Successor Predecessor
Fair value of common stock       $ 3.00     $ 3.25
Series A Convertible Preferred Stock [Member]              
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]              
Shares available for conversion   3,454,000 3,454,000        
Conversion floor price     $ 2.00        
Series B Convertible Preferred Stock [Member]              
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]              
Shares available for conversion   216,970 216,970        
Conversion floor price     $ 7.00        
Series A Warrant Exercise [Member]              
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]              
Shares available for conversion   3,454,000 4,101,625        
Conversion floor price     $ 2.00        
Inflamacore LlC License Agreement [Member] | Common Stock [Member]              
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]              
Warrants to purchase common shares 119,125 119,125 119,125 600,000 600,000 119,125